Edition:
United States

Agfa Gevaert NV (AGFB.BR)

AGFB.BR on Brussels Stock Exchange

3.89EUR
15 Dec 2017
Change (% chg)

€0.01 (+0.18%)
Prev Close
€3.89
Open
€3.90
Day's High
€3.92
Day's Low
€3.86
Volume
338,390
Avg. Vol
268,770
52-wk High
€4.94
52-wk Low
€3.34

Latest Key Developments (Source: Significant Developments)

Agfa Gevaert Q3 recurring EBITDA down at 593 million euros
Wednesday, 8 Nov 2017 01:45am EST 

Nov 8 (Reuters) - AGFA GEVAERT NV :Q3 REVENUE EUR ‍​593 MILLION VERSUS EUR 625 MILLION YEAR AGO.Q3 RESULT FOR THE PERIOD EUR 14‍​ MILLION VERSUS EUR 25 MILLION YEAR AGO.Q3 RECURRING EBITDA EUR 53 MILLION VERSUS EUR 63 MILLION YEAR AGO.  Full Article

Agfa Gevaert to study how to best organize its HealthCare IT activities within the Group
Wednesday, 11 Oct 2017 02:00am EDT 

Oct 11 (Reuters) - AGFA GEVAERT NV :IT IS IN BEST INTEREST TO BEGIN WITH ORGANIZING HEALTHCARE IT ACTIVITIES INTO STAND-ALONE LEGAL ENTITY STRUCTURE AND ORGANIZATION WITHIN AGFA-GEVAERT‍​.ORGANIZING TO START WITH LATIN AMERICA AND THE MIDDLE-EAST.  Full Article

Agfa Healthcare signs contract in Luxembourg
Thursday, 21 Sep 2017 08:13am EDT 

Sept 21 (Reuters) - Agfa Gevaert NV ::AGFA HEALTHCARE AND FÉDÉRATION DES HÔPITAUX LUXEMBOURGEOIS SIGN CONTRACT FOR NATIONAL VNA COVERING ALL HOSPITALS IN COUNTRY.  Full Article

Agfa Gevaert to study how to organise HealthCare IT activities
Wednesday, 23 Aug 2017 01:45am EDT 

Aug 23 (Reuters) - AGFA GEVAERT NV ::BOARD HAS ASKED MANAGEMENT TO STUDY HOW TO ORGANISE HEALTHCARE IT ACTIVITIES INTO A STAND-ALONE LEGAL ENTITY STRUCTURE AND ORGANISATION WITHIN AGFA-GEVAERT GROUP.INCREASING INDEPENDENCE OF HEALTHCARE IT ACTIVITIES WOULD BE A NATURAL PROGRESSION IN CONTINUED TRANSFORMATION OF GROUP.  Full Article

Agfa Gevaert Q2 income group share down at 26 million euros
Wednesday, 23 Aug 2017 01:45am EDT 

Aug 23 (Reuters) - AGFA GEVAERT NV ::Q2 REVENUE EUR 622 MILLION VERSUS EUR 645 MILLION YEAR AGO.Q2 NET CASH FROM OPERATING ACTIVITIES LOSS EUR 36 MILLION VERSUS PROFIT EUR 8 MILLION YEAR AGO.Q2 GROSS PROFIT EUR 213 MILLION VERSUS EUR 229 MILLION YEAR AGO.Q2 INCOME GROUP SHARE EUR 26 MILLION VERSUS EUR 38 MILLION YEAR AGO.AFTER A YEAR OF TRANSITION IN 2017, OUR HARDCOPY BUSINESS SHOULD NORMALIZE IN 2018.BOARD REQUESTED MANAGEMENT TO STUDY HOW TO ORGANIZE HEALTHCARE IT ACTIVITIES INTO A STAND-ALONE LEGAL ENTITY STRUCTURE AND ORGANIZATION WITHIN AGFA-GEVAERT GROUP.  Full Article

Agfa selected for development and supply of Malta voting documents
Tuesday, 20 Jun 2017 05:09am EDT 

June 20 (Reuters) - AGFA GEVAERT NV ::AGFA SELECTED FOR DEVELOPMENT AND SUPPLY OF MALTA VOTING DOCUMENTS.  Full Article

Agfa Gevaert Q1 result for the period down at 8 million euros
Tuesday, 9 May 2017 01:55am EDT 

May 9 (Reuters) - AGFA GEVAERT NV ::Q1 REVENUE EUR 588 MILLION ($642.3 MILLION) VERSUS EUR 603 MILLION YEAR AGO.Q1 RECURRING EBITDA EUR 39 MILLION VERSUS EUR 48 MILLION YEAR AGO.Q1 RECURRING EBIT EUR 26 MILLION VERSUS EUR 34 MILLION YEAR AGO.Q1 RESULT FOR THE PERIOD EUR 8 MILLION VERSUS EUR 10 MILLION YEAR AGO.REITERATES TARGET OF REDUCING TOP LINE DECLINE AND ULTIMATELY RETURNING TO GROWTH IN MEDIUM TERM.SAYS ON AVERAGE, RECURRING EBITDA SHOULD BE KEPT AROUND 10% OF REVENUE IN COMING YEARS.  Full Article

Agfa Gevaert Q4 recurring EBITDA up 16.9 percent to 76 million euros
Wednesday, 8 Mar 2017 02:30am EST 

Agfa Gevaert NV : Q4 revenue 664 million euros ($701.65 million) versus 672 million euros year ago . Q4 recurring EBITDA 76 million euros versus 65 million euros year ago . Q4 net cash 60 million euros versus 63 million euros year ago . Positive evolution is expected to continue in 2017 .Expects that it will be able to keep the recurring EBITDA margin close to or above 10 percent of revenue in 2017.  Full Article

Agfa Gevaert Q3 revenue down at 625 million euros
Wednesday, 9 Nov 2016 01:45am EST 

Agfa Gevaert NV : Q3 revenue of 625 million euros ($700.69 million) versus 661 million euros year ago . Q3 recurring EBITDA 63 million euros versus 60 million euros year ago . Q3 profit 25 million euros versus 33 million euros year ago . Q3 net cash from (used in) operating activities 35 million euros versus 34 million euros year ago .Expects full year recurring EBITDA to reach 10 pct of revenue.  Full Article

CompuGroup Medical SE says Agfa-Gevaert NV board resolved to enter non-exclusive discussions with co
Tuesday, 8 Nov 2016 03:19pm EST 

CompuGroup Medical SE : CompuGroup Medical SE - confirms continued discussions with Agfa-Gevaert NV . CompuGroup Medical SE-board of Agfa-Gevaert NV resolved to enter non-exclusive discussions with co concerning potential takeover of Agfa-Gevaert NV . CompuGroup Medical SE-board of Agfa-Gevaert NV resolved to allow compuGroup Medical SE to conduct "a (however limited) due diligence" .CompuGroup Medical SE - board of co points out that implementation of transaction still uncertain and dependent on different conditions being met.  Full Article

BRIEF-Agfa Gevaert Q3 recurring EBITDA down at 593 million euros

* Q3 REVENUE EUR ‍​593 MILLION VERSUS EUR 625 MILLION YEAR AGO